10 ML bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injection [Marcaine with Epinephrine]
- RxCUI
- 1867612
- RxNorm name
- 10 ML bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injection [Marcaine with Epinephrine]
- Display name
- MARCAINE WITH EPINEPHrine (Injectable)
- Full name
- 10 ML bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injection [Marcaine with Epinephrine]
- Term type
- SBD
- Status
- Active
- Strength
- 2.5-0.005 mg/ml
- Dose form
- Injection 10 ml
- Route
- Injectable
- Updated
- 2026-10-27 17:49:51
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032017
- Active start
- 032017
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| bupivacaine hydrochloride | 2.5 MG / 1 ML | bupivacaine | bupivacaine hydrochloride |
| epinephrine bitartrate | 5 MCG / 1 ML | epinephrine | epinephrine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bupivacaine | 1815 |
| epinephrine | 3992 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Marcaine 0.25 % / EPINEPHrine 1:200,000 per 10 ML Injection | 1 | NAMES |
| RxNorm Name | 10 ML bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injection [Marcaine with Epinephrine] | 1 | NAMES |
| RxNorm Synonym | Marcaine 0.25 % / EPINEPHrine 1:200,000 per 10 ML Injection | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1867612 | 1 | CODES |
| MMSL_CODE | MTH_RXN_BD14937 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0409-1746-10 | 0409-1746 | Marcaine with Epinephrine BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Hospira, Inc. | NDA016964 |
| 0409-5738-10 | 0409-5738 | Marcaine with Epinephrine BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | NDA016964 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 0409-5738-10 0409-5738 00409573810 00409573801 1867612 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | Marcaine 0.25 % / EPINEPHrine 1:200,000 in 10 ML Injection [PSN] · 10 ML bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injection [Marcaine with Epinephrine] [SBD] · Marcaine 0.25 % / EPINEPHrine 1:200,000 per 10 ML Injection [SY] | 3 | 38 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | 20260529 |
| 93cf0914-de08-4ec6-8f8c-d663243b9958 | Marcaine 0.25 % / EPINEPHrine 1:200,000 in 10 ML Injection [PSN] · 10 ML bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injection [Marcaine with Epinephrine] [SBD] · Marcaine 0.25 % / EPINEPHrine 1:200,000 per 10 ML Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | 20240202 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261023 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261014 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260529 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260423 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20251106 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250828 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250825 |
| 93cf0914-de08-4ec6-8f8c-d663243b9958 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Standard Chem. & Pharm. Co., Ltd. Plant II | 20240202 |
| b7b92d6e-11b4-4da9-9796-9c667b69fcb9 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | epinephrine | |
| ATC | R03AA | Alpha- and beta-adrenoreceptor agonists | ATC1-4 | epinephrine | |
| ATC | N01BB | Amides | ATC1-4 | bupivacaine | |
| ATC | B02BC | Local hemostatics | ATC1-4 | epinephrine | |
| ATC | A01AD | Other agents for local oral treatment | ATC1-4 | epinephrine | |
| ATC | S01EA | Sympathomimetics in glaucoma therapy | ATC1-4 | epinephrine | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | epinephrine | |
| FDASPL | D000577 | Amides | CHEM | has_chemical_structure | bupivacaine |
| FDASPL | D002395 | Catecholamines | CHEM | has_chemical_structure | epinephrine |
| FDASPL | N0000175552 | alpha-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | bupivacaine |
| FDASPL | N0000175555 | beta-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175570 | Catecholamine | EPC | has_epc | epinephrine |
| FDASPL | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine hydrochloride |
| MEDRT | D004837 | Epinephrine | CHEM | has_ingredient | epinephrine |
| MEDRT | D000402 | Airway Obstruction | DISEASE | may_treat | epinephrine |
| MEDRT | D000707 | Anaphylaxis | DISEASE | may_treat | epinephrine |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | epinephrine |
| MEDRT | D001919 | Bradycardia | DISEASE | may_treat | epinephrine |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | epinephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | epinephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | epinephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | epinephrine |
| MEDRT | D006323 | Heart Arrest | DISEASE | may_treat | epinephrine |
| MEDRT | D006327 | Heart Block | DISEASE | may_treat | epinephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | epinephrine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine hydrochloride |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | epinephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | epinephrine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | epinephrine |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009921 | Adrenergic beta1-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009922 | Adrenergic beta2-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine |
| MEDRT | N0000008298 | Arterial Vasoconstriction | PE | has_pe | epinephrine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | epinephrine |
| MEDRT | N0000009944 | Decreased Intraocular Aqueous Secretion | PE | has_pe | epinephrine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine |
| MEDRT | N0000009014 | Decreased Uterine Smooth Muscle Contraction or Tone | PE | has_pe | epinephrine |
| MEDRT | N0000009070 | Hemostasis Alteration | PE | has_pe | epinephrine |
| MEDRT | N0000178478 | Increased Blood Pressure | PE | has_pe | epinephrine |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | N0000009808 | Positive Chronotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009809 | Positive Inotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009820 | Pupillary Dilation | PE | has_pe | epinephrine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2.5 MG/ML / 0.005 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 10 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA016964 |
| NAMES | Prescribable Synonym | Marcaine 0.25 % / EPINEPHrine 1:200,000 in 10 ML Injection |
| NAMES | Tallman Synonym | 10 ML BUPivacaine hydrochloride 2.5 MG/ML / EPINEPHrine 0.005 MG/ML Injection [Marcaine with EPINEPHrine] |
| NAMES | Tallman Synonym | Marcaine 0.25 % / EPINEPHrine 1:200,000 per 10 ML Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |